Analyst Research

Report Title Price
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Directors Deals Ltd.
$12.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sorin SpA announces CE mark approval for CROWN PRT Heart Valve


Thursday, 24 Jul 2014 03:30am EDT 

Sorin SpA:Says it has been granted CE mark certification for its innovative stented aortic bioprosthesis CROWN PRT.CROWN PRT is commercially available in Europe.In treatment of aortic valve disease, replacement of native aortic valve with stented bioprosthesis represents standard technique.Says standard technique to provide older patients with performing and durable solution, while relieving them from discomfort of lifelong oral anticoagulation therapy. 

Company Quote

1.92
-0.01 -0.52%
10:24am EST